3wkc

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "3wkc" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
+
{{STRUCTURE_3wkc| PDB=3wkc | SCENE= }}
 +
===Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor===
 +
{{ABSTRACT_PUBMED_24656800}}
-
The entry 3wkc is ON HOLD
+
==Function==
 +
[[http://www.uniprot.org/uniprot/HYES_HUMAN HYES_HUMAN]] Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid, 12-phosphonooxy-octadec-9E-enoic acid, and p-nitrophenyl phospate.<ref>PMID:12574508</ref> <ref>PMID:12574510</ref>
-
Authors: Amano, Y., Yamaguchi, T., Tanabe, E.
+
==About this Structure==
 +
[[3wkc]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3WKC OCA].
-
Description: Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor
+
==Reference==
 +
<ref group="xtra">PMID:024656800</ref><references group="xtra"/><references/>
 +
[[Category: Amano, Y.]]
 +
[[Category: Tanabe, E.]]
 +
[[Category: Yamaguchi, T.]]
 +
[[Category: Hydrolase]]
 +
[[Category: Hydrolase-hydrolase inhibitor complex]]

Revision as of 09:44, 16 April 2014

Template:STRUCTURE 3wkc

Contents

Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor

Template:ABSTRACT PUBMED 24656800

Function

[HYES_HUMAN] Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid, 12-phosphonooxy-octadec-9E-enoic acid, and p-nitrophenyl phospate.[1] [2]

About this Structure

3wkc is a 1 chain structure. Full crystallographic information is available from OCA.

Reference

  • Amano Y, Yamaguchi T, Tanabe E. Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography. Bioorg Med Chem. 2014 Apr 15;22(8):2427-34. doi: 10.1016/j.bmc.2014.03.001. Epub , 2014 Mar 12. PMID:24656800 doi:http://dx.doi.org/10.1016/j.bmc.2014.03.001
  1. Cronin A, Mowbray S, Durk H, Homburg S, Fleming I, Fisslthaler B, Oesch F, Arand M. The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1552-7. Epub 2003 Feb 6. PMID:12574508 doi:10.1073/pnas.0437829100
  2. Newman JW, Morisseau C, Harris TR, Hammock BD. The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1558-63. Epub 2003 Feb 6. PMID:12574510 doi:10.1073/pnas.0437724100

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools